Scientists identified a driver of aggressive prostate cancer and a potential way to stop drug-resistant tumors forming.

Flu tests are coming back positive at higher rates than is typical for early fall in several Western states, data suggests.

A phase 2/3 trial of BioNTech's immunotherapy for head and neck cancer, BNT113, has failed to meet its objective, but the ...

Health Secretary Robert F. Kennedy Jr. announced a department-wide effort Thursday to study and treat possible vaccine ...

Slowing protein production to just a trickle might help Spider-Man control the level of his superpowers, Lieberman says. He ...

New research shows that the m6A reader protein YTHDF2 promotes melanoma progression by destabilizing HMOX1 mRNA and shielding ...

Spread the love“`html Imagine a world where a single treatment could potentially cure a debilitating chronic illness, not ...

Researchers at University Medical Centre Utrecht have published a formal response defending their nationwide self-controlled ...

INTerpath-001 data to be presented in Presidential Symposium, featuring the first Phase 3 results for investigational ...

In an era where AI allows "anyone to do a decent job"Using generative AI, even people with little experience can now create ...